Gardner Middlebrook

2.3k total citations · 1 hit paper
44 papers, 980 citations indexed

About

Gardner Middlebrook is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Gardner Middlebrook has authored 44 papers receiving a total of 980 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 17 papers in Epidemiology and 11 papers in Surgery. Recurrent topics in Gardner Middlebrook's work include Tuberculosis Research and Epidemiology (16 papers), Mycobacterium research and diagnosis (14 papers) and Infectious Diseases and Tuberculosis (7 papers). Gardner Middlebrook is often cited by papers focused on Tuberculosis Research and Epidemiology (16 papers), Mycobacterium research and diagnosis (14 papers) and Infectious Diseases and Tuberculosis (7 papers). Gardner Middlebrook collaborates with scholars based in United States. Gardner Middlebrook's co-authors include Maurice L. Cohn, Charles M. Coleman, Werner B. Schaefer, William F. Russell, Z Reggiardo, Mayer B. Goren, R. Ehrlich, J. Morton, Philip S. Brachman and Heinz F. Eichenwald and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Gardner Middlebrook

39 papers receiving 781 citations

Hit Papers

Some Observations on the Pathogenicity of Isoniazid-Resis... 1953 2026 1977 2001 1953 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gardner Middlebrook United States 16 525 488 178 165 108 44 980
S L Morris United States 18 672 1.3× 643 1.3× 224 1.3× 326 2.0× 133 1.2× 34 1.1k
B. G. Maegraith United Kingdom 21 315 0.6× 157 0.3× 197 1.1× 224 1.4× 104 1.0× 129 1.6k
P. S. Jackett United Kingdom 17 553 1.1× 463 0.9× 131 0.7× 278 1.7× 208 1.9× 23 936
F Kuze Japan 16 541 1.0× 447 0.9× 108 0.6× 143 0.9× 98 0.9× 35 1.1k
B. C. Harinath India 15 606 1.2× 246 0.5× 161 0.9× 175 1.1× 44 0.4× 109 931
Alfred G. Karlson United States 15 303 0.6× 459 0.9× 186 1.0× 119 0.7× 33 0.3× 66 782
J.M. Grange United Kingdom 20 827 1.6× 706 1.4× 262 1.5× 161 1.0× 263 2.4× 46 1.3k
L.A.E. Ashworth United Kingdom 26 154 0.3× 545 1.1× 108 0.6× 393 2.4× 236 2.2× 51 1.4k
B. R. Andersen United States 15 350 0.7× 349 0.7× 83 0.5× 192 1.2× 250 2.3× 38 858
El Moukhtar Aliouat France 24 916 1.7× 1.2k 2.5× 128 0.7× 131 0.8× 77 0.7× 79 1.6k

Countries citing papers authored by Gardner Middlebrook

Since Specialization
Citations

This map shows the geographic impact of Gardner Middlebrook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gardner Middlebrook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gardner Middlebrook more than expected).

Fields of papers citing papers by Gardner Middlebrook

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gardner Middlebrook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gardner Middlebrook. The network helps show where Gardner Middlebrook may publish in the future.

Co-authorship network of co-authors of Gardner Middlebrook

This figure shows the co-authorship network connecting the top 25 collaborators of Gardner Middlebrook. A scholar is included among the top collaborators of Gardner Middlebrook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gardner Middlebrook. Gardner Middlebrook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Middlebrook, Gardner. (2019). Isoniazid-Resistance and Catalase Activity of Tubercle Bacilli1. American Review of Tuberculosis. 3 indexed citations
2.
Middlebrook, Gardner. (2015). Méthodes Expérimentales D'Étude du Vaccin BCG. American Review of Respiratory Disease.
3.
Sharma, Somesh & Gardner Middlebrook. (1976). Antibacterial activity of stimulated guinea pig peritoneal exudate cell culture supernates. Cellular Immunology. 24(1). 123–131. 4 indexed citations
4.
Reggiardo, Z & Gardner Middlebrook. (1974). Delayed-Type Hypersensitivity and Immunity Against Aerogenic Tuberculosis in Guinea Pigs. Infection and Immunity. 9(5). 815–820. 9 indexed citations
5.
Reggiardo, Z & Gardner Middlebrook. (1974). SEROLOGICALLY ACTIVE GLYCOLIPID FAMILIES FROM MYCOBACTERIUM BOVIS BCG. American Journal of Epidemiology. 100(6). 469–476. 26 indexed citations
6.
Middlebrook, Gardner, et al.. (1974). Sterilization of Listeria monocytogenes by guinea pig peritoneal exudate cell cultures. Cellular Immunology. 14(2). 270–283. 14 indexed citations
7.
Brachman, Philip S., R. Ehrlich, Heinz F. Eichenwald, et al.. (1964). Standard Sampler for Assay of Airborne Microorganisms. Science. 144(3624). 1295–1295. 10 indexed citations
8.
Brachman, Philip S., R. Ehrlich, Heinz F. Eichenwald, et al.. (1964). Standard Sampler for Assay of Airborne Microorganisms. Science. 144(3624). 1295–1295. 76 indexed citations
9.
Cohn, Maurice L., William F. Russell, & Gardner Middlebrook. (1960). Effects of Carbon Dioxide and Daylight in Culturing Tubercle Bacilli. American Review of Respiratory Disease. 82(4). 1 indexed citations
10.
Middlebrook, Gardner, et al.. (1960). UNCLASSIFIED MYCOBACTERIA. PEDIATRICS. 26(4). 563–565. 1 indexed citations
11.
Levy, David M., et al.. (1960). Effect of Pyridoxine on Concentrations of Active Isoniazid in Serum. American Review of Respiratory Disease. 81(1P1). 102–104.
12.
Russell, William F., et al.. (1959). COMBINED DRUG TREATMENT OF TUBERCULOSIS. IV. BACTERIOLOGIC STUDIES ON THE SPUTUM AND RESECTED PULMONARY LESIONS OF TUBERCULOUS PATIENTS. Journal of Clinical Investigation. 38(8). 1376–1383. 7 indexed citations
13.
Russell, William F., et al.. (1959). COMBINED DRUG TREATMENT OF TUBERCULOSIS. III. CLINICAL APPLICATION OF THE PRINCIPLES OF APPROPRIATE AND ADEQUATE CHEMOTHERAPY TO THE TREATMENT OF PULMONARY TUBERCULOSIS. Journal of Clinical Investigation. 38(8). 1366–1375. 19 indexed citations
14.
Robinson, Arthur & Gardner Middlebrook. (1958). Isoniazid for Treatment of Tuberculous Meningitis. PEDIATRICS. 21(1). 162–162. 1 indexed citations
15.
Coleman, Charles M. & Gardner Middlebrook. (1957). Interface Enrichment of Methylene Blue by Fatty Acids with Microanalytic Applications. Science. 126(3265). 163–163. 2 indexed citations
16.
Grow, John B., et al.. (1956). The Handling of the Poor Risk Patient with Pulmonary Tuberculosis: Antimicrobial Therapy, Cardio-Pulmonary Function and Surgery*. Diseases of the Chest. 29(3). 266–276. 3 indexed citations
17.
Middlebrook, Gardner, et al.. (1954). Clinical Evaluation of Isoniazid. American Review of Tuberculosis. 70(6). 1102–1103. 41 indexed citations
18.
Russell, William F., et al.. (1954). Ambulation of Patients with Pulmonary Tuberculosis Under Protection of Chemotherapy ,. American Review of Tuberculosis. 70(6). 1030–1041. 9 indexed citations
19.
Middlebrook, Gardner & Maurice L. Cohn. (1953). Some Observations on the Pathogenicity of Isoniazid-Resistant Variants of Tubercle Bacilli. Science. 118(3063). 297–299. 177 indexed citations breakdown →
20.
Middlebrook, Gardner. (1952). Antigens of tubercle bacillus involved in hemagglutination and hemolysis reactions.. PubMed. 28(7). 474–5. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026